from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3731/ligC

LFCtreatmentdescriptionclass of inhibitor

0.898

Amikacinug/mL Amikacintranslation

1.468

Cap5-10ug/mL Capreomycintranslation

0.710

Rox10-50 ug/mL Roxithromycintranslation

0.754

SM2-5 ug/mL Streptomycintranslation

1.199

Tet5-10 ug/mL Tetracyclinetranslation

0.335

Rif0.2-5ug/mL Rifampicintranscription

-0.443

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.780

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.270

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.565

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.545

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.101

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.394

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.297

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.666

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.093

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.327

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.257

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.905

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.241

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.255

Nigericin50 uM Nigericinrespiration

-0.037

TRC10-150 ug/mL Triclosanrespiration

-0.498

TRZ10-25 ug/mL Thioridazinerespiration

0.792

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.319

menadione6-10 ug/mL Menadionerespiration

0.143

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.152

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.507

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.502

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.247

NRP_1Non-replicating persistence stage 1dosRassociated

0.348

Amp0.2mg/mL AmpicillincellWall

0.035

Cephalexin20-100 ug/mL CephalexincellWall

0.534

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.158

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.296

EMB10-20 ug/mL EthambutolcellWall

0.567

Eta12-40 ug/mL EthionamidecellWall

0.549

INH0.2-0.4 ug/mL IsoniazidcellWall

0.786

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.227

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.213

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.065

BZA0.12 mg/mL BenzamidearomaticAmides

-0.218

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.224

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.249

H2O24 mM hydrogen peroxideDNAdamaging

0.376

Levo10 ug/mL LevofloxacinDNAdamaging

-0.644

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.106

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.580

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.928

UVUV-irradiationDNAdamaging

-0.730

ARP41-4 ug/mL Antitubercular compound ARP4?

0.215

Antimycin12.5-50 ug/mL Antimycin A?

0.107

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

0.569

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.922

PA8240.2-2 ug/mL PA-824?

-0.615

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.188

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.274

Verapamil50 uM Verapamil?

0.690

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.144

methoxatin10-20 ug/mL Methoxatin?